TokenPost·
Zymeworks Presents Phase 1 ZW191 Activity in Resistant Ovarian Cancer
The heavily pretreated study population had platinum-resistant disease. The response-rate analysis focused on high-grade serous ovarian cancer.
More news
- TokenPostHouthis Vow Continued Attacks on Riyadh’s King Khalid International Airport
- TokenPostMeta Puts Maximum Exposure to Two Data Center Ventures at $68.4 Billion
- Crypto BriefingNvidia and SPIL plan 15x expansion of co-packaged optics capacity by mid-2027
- Crypto BriefingHouthis vow continued attacks on Saudi Arabia’s King Khalid airport
- TokenPostLighter Token Falls 1.6% to $3.21 in Saturday Market Snapshot
- TokenPostCrypto Market Cap Falls 3.65% to $2.71 Trillion in 24 Hours